{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:01:47Z","timestamp":1791925307748,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jsps.2023.101934","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T11:54:53Z","timestamp":1703332493000},"page":"101934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetics and tissue distribution of vigabatrin enantiomers in rats"],"prefix":"10.1007","volume":"32","author":[{"given":"Qiang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Die","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Fang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"10.1016\/j.jsps.2023.101934_b0005","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpba.2009.03.030","article-title":"A direct HPLC method for the resolution and quantitation of the R-(-)- and S-(+)-enantiomers of vigabatrin (gamma-vinyl-GABA) in pharmaceutical dosage forms using teicoplanin aglycone chiral stationary phase","volume":"50","author":"Al-Majed","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jsps.2023.101934_b0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1059-1311(96)80043-4","article-title":"Vigabatrin dosing during haemodialysis","volume":"5","author":"Bachmann","year":"1996","journal-title":"Seizure"},{"key":"10.1016\/j.jsps.2023.101934_b0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0404.2011.01596.x","article-title":"Mechanism of action of vigabatrin: correcting misperceptions","volume":"192","author":"Ben-Menachem","year":"2011","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"2","key":"10.1016\/j.jsps.2023.101934_b0020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/epi.12490","article-title":"Frontal lobe seizures: from clinical semiology to localization","volume":"55","author":"Bonini","year":"2014","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.jsps.2023.101934_b0025","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.ophtha.2004.03.036","article-title":"Characteristic retinal atrophy with secondary \u201cinverse\u201d optic atrophy identifies vigabatrin toxicity in children","volume":"111","author":"Buncic","year":"2004","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.jsps.2023.101934_b0030","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.jsps.2023.101934_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25122738","article-title":"Chiral aspects of local anesthetics","volume":"25","author":"\u010ci\u017em\u00e1rikov\u00e1","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.jsps.2023.101934_b0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jchromb.2017.10.037","article-title":"Determination of the R(-) and S(+)-enantiomers of vigabatrin in human plasma by ultra-high-performance liquid chromatography and tandem mass-spectrometry","volume":"1070","author":"Duhamel","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/j.jsps.2023.101934_b0045","first-page":"480","article-title":"Pharmacokinetics and metabolism of vigabatrin following a single oral dose of [14C]vigabatrin in healthy male volunteers","volume":"21","author":"Durham","year":"1993","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.jsps.2023.101934_b0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.yebeh.2008.01.003","article-title":"Modern management of epilepsy: a practical approach","volume":"12","author":"Elger","year":"2008","journal-title":"Epilepsy Behav. : E&B"},{"issue":"6","key":"10.1016\/j.jsps.2023.101934_b0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-199630060-00001","article-title":"Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine","volume":"30","author":"Elwes","year":"1996","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.jsps.2023.101934_b0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1212\/WNL.46.1.54","article-title":"A double-blind, placebo-controlled study of vigabatrin three g\/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort","volume":"46","author":"French","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jsps.2023.101934_b0065","doi-asserted-by":"crossref","unstructured":"Gale K. Role of GABA in the genesis of chemoconvulsant seizures. Toxicology letters. 1992;64-65 Spec No:417-428.Doi: 10.1016\/0378-4274(92)90215-6.","DOI":"10.1016\/0378-4274(92)90215-6"},{"issue":"2","key":"10.1016\/j.jsps.2023.101934_b0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/019262339001800201","article-title":"Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor","volume":"18","author":"Gibson","year":"1990","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.jsps.2023.101934_b0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5603\/PJNNS.a2021.0063","article-title":"Vigabatrin - new data on indications and safety in paediatric epilepsy","volume":"55","author":"Golec","year":"2021","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.jsps.2023.101934_b0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.seizure.2016.11.022","article-title":"Drug development for refractory epilepsy: The past 25 years and beyond","volume":"44","author":"Golyala","year":"2017","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.jsps.2023.101934_b0085","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/clpt.1986.227","article-title":"Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer","volume":"40","author":"Haegele","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.jsps.2023.101934_b0090","first-page":"749","article-title":"Gabapentin, pregabalin and vigabatrin quantification in human serum by GC-MS after hexyl chloroformate derivatization","volume":"40","author":"Hlo\u017eek","year":"2016","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.jsps.2023.101934_b0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neurol.2015.01.563","article-title":"Hippocampus and epilepsy: Findings from human tissues","volume":"171","author":"Huberfeld","year":"2015","journal-title":"Rev. Neurol."},{"issue":"4","key":"10.1016\/j.jsps.2023.101934_b0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.mcn.2010.01.008","article-title":"Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats","volume":"43","author":"Jammoul","year":"2010","journal-title":"Mol. Cell Neurosci."},{"issue":"5","key":"10.1016\/j.jsps.2023.101934_b0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1471-4159.1977.tb10721.x","article-title":"gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice","volume":"29","author":"Jung","year":"1977","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.jsps.2023.101934_b0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3940(02)01166-7","article-title":"Changed vesicular GABA transporter immunoreactivity in the gerbil hippocampus following spontaneous seizure and vigabatrin administration","volume":"335","author":"Kang","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jsps.2023.101934_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0169-2607(94)90048-5","article-title":"An algorithm for estimating the terminal half-life in pharmacokinetic studies","volume":"42","author":"Kowalski","year":"1994","journal-title":"Comput. Methods Programs Biomed."},{"issue":"2","key":"10.1016\/j.jsps.2023.101934_b0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1684\/j.1950-6945.2002.tb00479.x","article-title":"Seizure-induced hippocampal damage in the mature and immature brain","volume":"4","author":"Lado","year":"2002","journal-title":"Epileptic Disorders : Int. Epilepsy J. Videotape"},{"issue":"6","key":"10.1016\/j.jsps.2023.101934_b0125","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cbf.3651","article-title":"Abnormal neuronal damage and inflammation in the hippocampus of kainic acid-induced epilepsy mice","volume":"39","author":"Li","year":"2021","journal-title":"Cell Biochem. Funct."},{"issue":"5","key":"10.1016\/j.jsps.2023.101934_b0130","first-page":"556","article-title":"Vigabatrin-induced cytolytic hepatitis","volume":"25","author":"Locher","year":"2001","journal-title":"Gastroenterol. Clin. Biol."},{"issue":"4","key":"10.1016\/j.jsps.2023.101934_b0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/088307389701200407","article-title":"Optimizing the indication of vigabatrin in children with refractory epilepsy","volume":"12","author":"Lortie","year":"1997","journal-title":"J. Child Neurol."},{"issue":"2","key":"10.1016\/j.jsps.2023.101934_b0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1517\/17425255.3.2.149","article-title":"Stereoselectivity in drug metabolism","volume":"3","author":"Lu","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"11","key":"10.1016\/j.jsps.2023.101934_b0145","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(05)70199-X","article-title":"The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial","volume":"4","author":"Lux","year":"2005","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.jsps.2023.101934_b0150","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/jama.2022.10597","article-title":"Review of antiseizure medications for adults with epilepsy","volume":"328","author":"Maggiani","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsps.2023.101934_b0155","doi-asserted-by":"crossref","first-page":"17834","DOI":"10.1038\/s41598-020-74932-x","article-title":"A retrospective cross-sectional study to determine chirality status of registered medicines in Tanzania","volume":"10","author":"Mwamwitwa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsps.2023.101934_b0160","first-page":"127","article-title":"Plasma vigabatrin enantiomer ratios in adults and children","volume":"30","author":"Nagarajan","year":"1993","journal-title":"Clin. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jsps.2023.101934_b0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","article-title":"Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial","volume":"16","author":"O'Callaghan","year":"2017","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.jsps.2023.101934_b0170","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s40262-013-0088-z","article-title":"Drug interactions with the newer antiepileptic drugs (AEDs)\u2013Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders","volume":"52","author":"Patsalos","year":"2013","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.jsps.2023.101934_b0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2125.1990.tb03772.x","article-title":"Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children","volume":"30","author":"Rey","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.jsps.2023.101934_b0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00003088-199223040-00003","article-title":"Vigabatrin","volume":"23","author":"Rey","year":"1992","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.jsps.2023.101934_b0185","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41582-022-00651-8","article-title":"The metabolic basis of epilepsy","volume":"18","author":"Rho","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jsps.2023.101934_b0190","unstructured":"Ruether K, Pung T, Kellner U, Schmitz B, Hartmann C, Seeliger M. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin. Archives of ophthalmology (Chicago, Ill : 1960). 1998;116(6):817-819."},{"issue":"Pt A","key":"10.1016\/j.jsps.2023.101934_b0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2016.01.012","article-title":"A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience","volume":"57","author":"Schwarz","year":"2016","journal-title":"Epilepsy Behav. : E&B"},{"key":"10.1016\/j.jsps.2023.101934_b0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejps.2016.03.018","article-title":"Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance","volume":"94","author":"Scotcher","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.jsps.2023.101934_b0205","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1535370221989263","article-title":"Influence of glutamate and GABA transport on brain excitatory\/inhibitory balance","volume":"246","author":"Sears","year":"2021","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.jsps.2023.101934_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jsps.2023.101934_b0215","article-title":"Electrophoretic delivery of \u03b3-aminobutyric acid (GABA) into epileptic focus prevents seizures in mice","volume":"147","author":"Slezia","year":"2019","journal-title":"J. Visual. Exp. : Jove"},{"issue":"1","key":"10.1016\/j.jsps.2023.101934_b0220","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00213-016-4446-z","article-title":"Neurobehavioral effects of vigabatrin and its ability to induce DNA damage in brain cells after acute treatment in rats","volume":"234","author":"Sousa","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.jsps.2023.101934_b0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/03602532.2014.984814","article-title":"Types of stereoselectivity in drug metabolism: a heuristic approach","volume":"47","author":"Testa","year":"2015","journal-title":"Drug Metab. Rev."},{"issue":"10172","key":"10.1016\/j.jsps.2023.101934_b0230","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.jsps.2023.101934_b0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.seizure.2006.10.003","article-title":"The pharmacokinetics of vigabatrin in rat blood and cerebrospinal fluid","volume":"16","author":"Tong","year":"2007","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.jsps.2023.101934_b0240","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1528-1157.1999.tb00820.x","article-title":"Time course of the GABAergic effects of vigabatrin: is the time course of brain GABA related to platelet GABA-transaminase inhibition?","volume":"40","author":"Valdiz\u00e1n","year":"1999","journal-title":"Epilepsia"},{"issue":"20","key":"10.1016\/j.jsps.2023.101934_b0245","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1523\/JNEUROSCI.20-20-07657.2000","article-title":"Evidence that different cation chloride cotransporters in retinal neurons allow opposite responses to GABA","volume":"20","author":"Vardi","year":"2000","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.jsps.2023.101934_b0250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-4347(98)00269-2","article-title":"High-performance liquid chromatographic analysis of vigabatrin enantiomers in human serum by precolumn derivatization with o-phthaldialdehyde-N-acetyl-L-cysteine and fluorescence detection","volume":"716","author":"Vermeij","year":"1998","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jsps.2023.101934_b0255","unstructured":"Vigabatrin. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"issue":"1","key":"10.1016\/j.jsps.2023.101934_b0260","doi-asserted-by":"crossref","first-page":"e00456","DOI":"10.1002\/prp2.456","article-title":"Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use-limiting visual field defects","volume":"7","author":"Walters","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.jsps.2023.101934_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106536","article-title":"Preferential accumulation of the active S-(+) isomer in murine retina highlights novel mechanisms of vigabatrin-associated retinal toxicity","volume":"170","author":"Walters","year":"2021","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.jsps.2023.101934_b0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13318-018-0512-8","article-title":"Determination of the pharmacokinetics and tissue distribution of methyl 3,4-dihydroxybenzoate (MDHB) in mice using liquid chromatography-tandem mass spectrometry","volume":"44","author":"Wang","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.jsps.2023.101934_b0275","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1167\/iovs.05-0854","article-title":"Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer","volume":"47","author":"Wild","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.jsps.2023.101934_b0280","doi-asserted-by":"crossref","first-page":"e43889","DOI":"10.1371\/journal.pone.0043889","article-title":"Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423004292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423004292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T12:31:03Z","timestamp":1736166663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016423004292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1319016423004292"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101934","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and tissue distribution of vigabatrin enantiomers in rats","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"101934"}}